Negative signaling in B cells by surface immunoglobulins

The Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 PART 2, 1996, Pages

  Mayumi, Mitsufumi ^a   Sumimoto, Schin Ichi ^a   Kanazashi, Shu Ichi ^a   Hata, Daisuke ^a   Yamaoka, Koji ^a   Higaki, Yasunobu ^a   Ishigami, Tsuyoshi ^a   Kim, Kwang Myong ^a   Heike, Toshio ^a   Katamura, Kenji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

adhesion; apoptosis; B cell; CD40; IgM

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN;

ANTIGEN SPECIFICITY; APOPTOSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONFERENCE PAPER; HUMAN; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; HUMANS; LYMPHOMA, B-CELL; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030459165     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70072-6     Document Type: Article

References (102)

1. Positive selection of lymphocytes
2. Negative selection of lymphocytes
3. Cellular mechanisms of immunological tolerance
4. Mechanism of antigen-driven selection in germinal centres
5. The CD40 antigen and its ligand
6. The role of CD40 and its ligand in the regulation of the immune response
7. gp39-CD40 interactions are essential for germinal center formation and the development of B-cell memory
8. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation
9. Mice deficient for the CD40 ligand
10. Apoptosis in splenic B lymphocytes: regulation by protein kinase C and IL-4
11. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
12. Induction of self-tolerance in mature peripheral B lymphoytes
13. Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice
14. Breakdown of self-tolerance in anergic B lymphocytes
15. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes
16. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras
17. Peripheral deletion of self-reactive B-cells
18. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens
19. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death
20. Reduced life span of anergic self-reactive B-cells in a double-transgenic model
21. Anergic self-reactive B-cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions
22. The regulation of growth and differentiation of a murine B-cell lymphoma: II. the inhibition of WEHI 231 by anti-immunoglobulin antibodies
23. Lymphoma models for B cell activation and tolerance IV growth inhibition by anti-Ig of CH31 and CH33 B lymphoma cells
24. Rescue from anti-IgM-induced programmed cell death by the B-cell surface proteins CD20 and CD40
25. Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death
26. Involvement of LFA-1/intercellular adhesion molecule-1-dependent T-cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking
27. Growth regulation of a human mature B-cell line, B104, by anti-IgM and anti-IgD antibodies
28. Cross-linking of surface IgM or IgD causes differential biological effects in spite of overlap in tyrosine (de)phosphorylation profile
29. Anti-IgM-mediated growth inhibition of a human B lymphoma cell line is independent of phosphatidylinositol turnover and protein kinase C activation and involves tyrosine phosphorylation
30. Anti-immunoglobulin antibodies induce apoptosis in immature B-cell lymphomas
31. Role of T-cell-derived lymphokines in two models of B-cell tolerance
32. Cell death: the significance of apoptosis
33. Antigen-induced apoptosis in developing T-cells: a mechanism for negative selection of the T cell receptor repertoire
34. Programmed death of autoreactive thymocytes
35. Mechanism of antigen-driven selection in germinal centres
36. Glucocorticoid activation of a calcium-dependent endonulease in thymocyte nuclei leads to cell death
37. Lymphoma models for B-cell activation and tolerance: V. anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium
38. Cyclosporine A blocks surface IgM-mediated growth inhibition in an immature B lymphoma, BKS-2
39. Do all programmed cell deaths occur via apoptosis?
40. Anti-IgM but not anti-IgD antibodies inhibit cell division of normal human mature B-cells
41. Cyclosporin A and FK506 block the negative signaling mediated by surface IgM cross-linking in normal human mature B-cells
42. Plastic-immobilized anti-μ or anti-δ antibodies induce apoptosis in mature murine B lymphocytes
43. Hypercross-linking surface IgM or IgD receptors on mature B-cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40
44. Functional differences between immunoglobulins M and D expressed on the surface of an immature B-cell line
45. Immunoglobulin D and M mediate signals that are qualitatively different in B-cells with an immature phenotype
46. Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B-cell clonal populations
47. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen
48. Tyrosine phosphorylation of IgM- and IgD-associated molecules of a human B lymphoma cell line B104
49. Tyrosine phosphorylation of MB-1 B29 and HS1 proteins in human B-cells following receptor crosslinking
50. Induction of phosphatidylinositol turnover and Egr-1 mRNA expression by crosslinking of surface IgM and IgD in the human B-cell line B104
51. The B-cell antigen receptor complex structure and signal transduction
52. Cross-linking of membrane immunoglobulin D, in the abscence of T cell help, kills mature B cells in vivo
53. Cross-linking of surface IgG induces apoptosis in a bcl-2 expressing human follicular lymphoma line of mature B-cell phenotype
54. The IgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein
55. Two new proteins preferentially associated with membrane immunoglobulin D
56. Cell autonomous expression of IgD is not essential for the maturation of conventional B-cells
57. (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B-cells
58. Immunoglobulin D-deficient mice can mount normal immune responses to thymus-independent and -dependent antigens
59. Signal transduction pathways involved in B-cell induction
60. The B-cell antigen receptor structure and function of primary secondary tertiary and quaternary components
61. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4
62. Cyclosporin-A sensitive induction of NF-AT in murine B-cells
63. B-cells from CBA/N mice do not proliferate following ligation of CD40
64. Regulation of cell division of mature B-cells by ionomycin and phorbol ester
65. Positive and negative signals transduced through surface immunoglobulins in human B-cells
66. Pertussis toxin inhibits activation-induced cell death of human thymocytes pre-B leukemia cells and monocytes
67. Membrane IgM cross-linking is not coupled to protein kinase C translocation in WEHI-231 B lymphoma cells
68. Differential expression of a zink finger-encoding gene in response to positive versus negative signaling through receptor immunoglobulin in murine B lymphocytes
69. Differential induction of Egr-1 expression in WEHI-231 sublines does not correlate with apoptosis
70. blk kinase in signaling growth arrest and apoptosis
71. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells
72. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro
73. Distribution of cAMP in secondary follicles and its expression in B-cell apoptosis and CD40-mediated survival
74. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
75. Lymphoma models for B-cell activation and tolerance: VI. reversal of anti-Ig-mediated negative signaling by T-cell-derived lymphokines
76. Lymphoma models for B-cell activation and tolerance IX efficient reversal of anti-Ig-mediated growth inhibition by an activated TH2 clone
77. The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies: effects on B-cell proliferation versus growth inhibition (tolerance) of an immature B-cell lymphoma
78. Growth regulation of the B lymphoma cell line WEHI-231 by anti-immunoglobulin, lipopolysaccharide, and other bacterial products
79. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
80. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B-cell Ig isotype switch recombination and rescues B-cells from programmed cell death
81. Antibodies to murine CD40 protect normal and malignant B-cells from induced growth arrest
82. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B-cells
83. Regulation of germinal center B cell differentiation: role of the human APO-1/Fas (CD95) molecule
84. CD40 cross-linking inhibits specific antibody production by human B cells
85. A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels
86. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells
87. Inhibition of human B-cell lymphoma growth by CD40 stimulation
88. Growth inhibition of a B-cell clone mediated by ligation of IL-4 receptors or membrane IgM
89. Mechanisms involved in the inhibition of growth of a human B lymphoma cell line, B104, by anti-MHC class II antibodies
90. Protein kinase C mobilization in B lymphocytes differential isoenzyme translocation upon activation
91. Interleukin 4 protects chronic lymphocytic leukemic B-cells from death by apoptosis and upregulates Bcl-2 expression
92. Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population
93. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
94. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair
95. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice
96. Programmed cell death by bcl-2-dependent and -independent mechanisms in B lymphoma cells
97. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction
98. Adhesion through the LFA-1 (CD11a/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B-cells
99. Role of LFA-1/ICAM-1-dependent T-cell adhesion in CD40-mediated inhibition of anti-IgM antibody-induced B-cell death
100. The role of bcl-XL in CD40-mediated rescue from anti-m-induced apoptosis in WEHI-231 B lymphoma cells
101. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis
102. Follicular dendritic cells inhibit apoptosis in human B lymphocytes by a rapid and irreversible blockade of preexisting endonuclease